Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Creative Educational Concepts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Creative Educational Concepts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Targeting Unmet Patient Needs in Diffuse Large B-Cell Lymphoma (DLBCL): Emerging Strategies for the Interprofessional Healthcare Team

47:17
 
Share
 

Manage episode 326685736 series 2870185
Content provided by Creative Educational Concepts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Creative Educational Concepts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

This activity will review the failure rates of traditional therapies for DLBCL, such as R-CHOP, and evaluate patient-centric factors that contribute to disease progression and/or relapse. Expert faculty will then guide attendees through an evidence-based examination of the exigent need for more effective front-line therapeutic options in DLBCL, emphasizing practical clinical pearls and notable distinguishing features of novel and emerging treatment agents and their potential to optimize patient outcomes.
Supported by an independent educational grant from Genentech.

  continue reading

35 episodes

Artwork
iconShare
 
Manage episode 326685736 series 2870185
Content provided by Creative Educational Concepts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Creative Educational Concepts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

This activity will review the failure rates of traditional therapies for DLBCL, such as R-CHOP, and evaluate patient-centric factors that contribute to disease progression and/or relapse. Expert faculty will then guide attendees through an evidence-based examination of the exigent need for more effective front-line therapeutic options in DLBCL, emphasizing practical clinical pearls and notable distinguishing features of novel and emerging treatment agents and their potential to optimize patient outcomes.
Supported by an independent educational grant from Genentech.

  continue reading

35 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play